Pharmacokinetic and hemodynamic safety of two superparamagnetic agents, Endorem and Sinerem, in cirrhotic rats.
Bonnemain
B
B
Research and Development, Laboratoire Guerbet, Roissy CDG, France.
D000818:Animals; D003287:Contrast Media / Q000009:adverse effects* / Q000493:pharmacokinetics*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D006439:Hemodynamics / Q000187:drug effects*; D007501:Iron / Q000009:adverse effects* / Q000493:pharmacokinetics*; D008106:Liver Cirrhosis, Experimental / Q000378:metabolism* / Q000503:physiopathology; D058185:Magnetite Nanoparticles; D010087:Oxides / Q000009:adverse effects* / Q000493:pharmacokinetics*; D051381:Rats; D012449:Safety; D013535:Suspensions
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D013535:Suspensions; C097921:ferumoxtran-10; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide